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It is becoming increasingly apparent that mitochondria dysfunction plays an important 
role in the pathogenesis of Huntington’s disease (HD), but the underlying mechanism 
is still elusive. Thus, there is a still need for further studies concerning the upstream 
events in the mitochondria dysfunction that could contribute to cell death observed in 
HD. Taking into account the fundamental role of the voltage-dependent anion-selective 
channel (VDAC) in mitochondria functioning, it is reasonable to consider the channel as 
a crucial element in HD etiology. Therefore, we applied inducible PC12 cell model of HD 
to determine the relationship between the effect of expression of wild type and mutant 
huntingtin (Htt and mHtt, respectively) on cell survival and mitochondria functioning in 
intact cells under conditions of undergoing cell divisions. Because after 48 h of Htt and 
mHtt expression differences in mitochondria functioning co-occurred with differences in 
the cell viability, we decided to estimate the effect of Htt and mHtt expression lasted for 
48 h on VDAC functioning. Therefore, we isolated VDAC from the cells and tested the 
preparations by black lipid membrane system. We observed that the expression of mHtt, 
but not Htt, resulted in changes of the open state conductance and voltage-dependence 
when compared to control cells cultured in the absence of the expression. Importantly, 
for all the VDAC preparations, we observed a dominant quantitative content of VDAC1, 
and the quantitative relationships between VDAC isoforms were not changed by Htt 
and mHtt expression. Thus, Htt and mHtt-mediated functional changes of VDAC, being 
predominantly VDAC1, which occur shortly after these protein appearances in cells, may 
result in differences concerning mitochondria functioning and viability of cells expressing 
Htt and mHtt. The assumption is important for better understanding of cytotoxicity as 
well as cytoprotection mechanisms of potential clinical application.
Keywords: VDac protein, huntington’s disease, mitochondria, huntingtin, intact cells, status of mitochondrial 
coupling
inTrODUcTiOn
Huntington’s disease (HD) is a fatal neurodegenerative disease, which is characterized by progres-
sive cognitive deterioration, psychiatric disturbances, and movement disorder with maximum 
degeneration occurring in striatum and deep layers of the cerebral cortex [e.g., Bonelli and 
Hofmann (1); Gövert and Schneider (2); Glajch and Sadri-Vakili (3)]. The disease is caused by the 
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expansion of the unstable trinucleotide CAG (glutamine codon) 
repeat region within the first exon of the gene encoding the 
protein huntingtin (Htt) that results in synthesis of its mutant 
form (mHtt) containing a sequence of 36 or more glutamines 
at N-terminus (4). The mechanism by which mHtt causes HD 
is still unknown although available data suggest that mitochon-
drial defects initiate the disease onset (5–10). Accordingly, 
over 130 review papers on the role of mitochondria in HD 
pathogenesis have been published till now. They address mHtt 
effects on mitochondrial bioenergetics and biogenesis, protein 
import complex assembly, fission and fusion, mitochondrial 
transport including Ca2+ and metal homeostasis, and the deg-
radation of damaged mitochondria via autophagy (mitophagy). 
Simultaneously, it is also evident that voltage-dependent anion-
selective channel (VDAC), regarded as a dynamic regulator, 
or even governor, of mitochondrial functions, contributes to 
affected phenomena directly or by interacting with the involved 
proteins [e.g., Colombini (11); Mannella and Kinnally (12); 
Shoshan-Barmatz et  al. (13); Maldonado and Lemasters (14); 
Martel et al. (15); Karachitos et al. (16)].
Because HD inheritance is autosomal dominant, the pre-
vailing view is that mHtt-mediated symptoms result from a 
toxic gain-of-function mechanism although loss-of-function 
mechanisms for both mHtt and Htt are also proposed (17, 18). 
Htt is localized mainly in cytoplasm and is known to exhibit 
anti-apoptotic properties (19) and to be required for mam-
malian embryogenesis and neurogenesis (20, 21). The domain 
model of Htt indicates the presence of domains important for 
protein interactions. Indeed, numerous reports indicate that Htt 
interacts with about 200 proteins, which represent a diverse 
array of biological functions, including synaptic transmission, 
cytoskeletal organization, signal transduction, gene expression 
regulation, and metabolism. Importantly, the interaction was also 
reported for human VDAC isoforms [e.g., Kaltenbach et al. (22); 
see also http://thebiogrid.org]. Thus, one could assume that the 
possible upstream events in mitochondria dysfunction resulting 
in HD may include VDAC (16).
Resolving the role of VDAC in HD pathogenesis may be 
important for the development of new therapeutic strategies 
concerning the disease as well as other neurodegenerative 
diseases. Moreover, the obtained results may also contribute to 
better understanding of VDAC role in cell death and to the 
development of efficient anti-cancer strategies. Accordingly, 
available data support an important role of VDAC in cancer 
cell survival [e.g., Maldonado and Lemasters (14); Leanza et al. 
(23); Shoshan-Barmatz et al. (24)]. Here, we used inducible PC12 
cell model of HD, i.e., PC12 HD-Q23 and PC12 HD-Q74 cycling 
cells, to determine the effect of short-term expression of Htt 
and mHtt on the cell viability and mitochondria functioning 
in intact cells as well as properties of VDAC isolated from the 
cells differing in viability and mitochondrial coupling status. 
The obtained results indicate that when compared with Htt, 
the cytotoxic effect of mHtt on PC12 cells is preceded by its 
different impact on the cell respiration and coincides with its 
different influence on the cell status of mitochondrial coupling 
and reconstituted VDAC properties.
MaTerials anD MeThODs
cell lines and growth conditions
PC12 cell lines were derived from pheochromocytoma of the rat 
adrenal medulla (25). PC12 HD-Q23 and PC12 HD-Q74 cells 
expressing exon 1 of the gene encoding huntingtin with 23 (Htt) 
or 74 (mHtt) repeats of glutamine residues were kindly provided 
by David Rubinsztein and Andreas Wyttenbach (University of 
Cambridge, UK). The cells were grown in TPP tissue culture 
T75 flasks, in the recommended high glucose (4.5 g/l) DMEM 
(Dulbecco’s Modified Eagle’s Medium) supplemented with 10% 
heat-inactivated horse serum, 5% fetal bovine serum, 2  mM 
l-glutamine, 100 units/ml penicillin G, 100 μg/ml streptomycin 
sulfate, and 0.25 μg/ml amphotericin B, in a humidified 5% CO2 
atmosphere at 37°C (Thermo Scientific Heracell 150i CO2 incu-
bator). Poly-l-ornithine hydrobromide (10 μg/ml) was applied 
as a coating reagent for culture flasks and plates. Expression of 
Htt and mHtt was induced by 1 μg/ml doxycycline and moni-
tored by their labeling with GFP (Figure S1 in Supplementary 
Material) fused to N-terminus of the exon 1. The expression 
was performed in DMEM without antibiotic and antimycotic 
compounds, for different period of time (from 4 to 48 h), and at 
cell confluence of approximately 80–90%.
estimation of cell Viability
Viability of PC12 HD-Q23 and PC12 HD-Q74 cells was esti-
mated in 24-well plates used for the cell culturing for a given 
period of time in the presence or absence of Htt and mHtt 
expression, respectively. The number of PC12 cells adhering to 
the bottom of the plates was counted using Zeiss Axiovert40 
phase-contrast microscope. To quantify results of the MTT 
cell proliferation colorimetric assay, UV-1650PC Shimadzu 
spectrophotometer (λ  =  570  nm) was applied. The assay is 
based on 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (thiazolyl blue – MTT) conversion to an insoluble 
purple formazan by cleavage of the tetrazolium ring by living 
cell dehydrogenase enzymes (26). After the proper duration 
of Htt and mHtt expression and control cultures without the 
expression, cells were incubated with MTT at a concentration 
of 0.25 mg per 1 ml of DMEM for 3 h at 37°C, and the created 
formazan was dissolved in acidic isopropanol (0.04M HCl in 
absolute isopropanol). To estimate the effect of Htt or mHtt, 
the change index was calculated between cells expressing Htt 
or mHtt and control cells, i.e., cultured for the same time but 
without Htt or mHtt expression.
Measurements of cell respiration and 
status of Mitochondrial coupling in 
intact cells
The cells expressing Htt or mHtt and control cells were washed 
and suspended in phosphate-buffered saline (PBS), pH 7.4. The 
rate of oxygen uptake by cells (2 × 106) was measured at 37°C in 
0.4 ml of high glucose DMEM without antibiotic and antimy-
cotic compounds, in a water-thermostated incubation chamber 
with a computer-controlled Clark-type O2 electrode (Oxygraph, 
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Hansatech, UK) (27–30). State 4 (oligomycin-resistant res-
piration) was enforced by addition of 2 μg/ml oligomycin (an 
inhibitor of mitochondrial ATPase), whereas state U (uncoupled 
state) was induced by FCCP (carbonyl cyanide p-trifluo-
romethoxyphenylhydrazone; an uncoupler) added in portions 
of 0.1 μM each to avoid respiration inhibition (Figure 2A). To 
estimate the status of mitochondrial coupling in intact cells, 
basal respiration, contribution of state 3 to basal respiration, 
and uncoupling capacity of FCCP were calculated (29, 31). The 
state 3 (oligomycin-inhabitable respiration) was calculated by 
subtracting state 4 from basal respiration. The contribution of 
state 3 to basal respiration was calculated as the ratio of state 3 
to basal respiration and corresponds to mitochondrial coupling 
efficiency. The uncoupling capacity of FCCP denotes the state 
U to state 4 ratio and corresponds to mitochondrial coupling 
capacity. To evaluate the effect of Htt or mHtt, the change index 
for the parameters was calculated between cells expressing Htt or 
mHtt and control cells (cultured for the same time but without 
Htt or mHtt expression).
isolation of VDac Proteins 
from Pc12 cells
Isolation of mitochondria was based on Gross et al. (32). After 
washing with PBS, PC12 cell pellet was transferred to Falcon 
tubes and washed twice with PBS at 4°C (10 min, 500 × g). The 
pellet was suspended in medium A (20 ml per 1 g of cells) con-
taining 10 mM saccharose, 200 mM mannitol, 5 mM Hepes-KOH 
(pH 7.4), 1 mM EGTA, 1 mM EDTA and protease inhibitor mix 
(Lab Empire, PIC002.1), homogenized with Dounce homog-
enizer, and centrifuged at 4°C, 10  min, 900 ×  g. The obtained 
supernatant was centrifuged at 4°C, 10  min, 13,000 ×  g, and 
the consecutive pellet was suspended in medium B containing 
10  mM sacharose, 200  mM mannitol, 5  mM Hepes-KOH (pH 
7.4), and 1 mM EGTA. The suspension was centrifuged at 4°C, 
10 min, 900 × g, and the obtained supernatant was centrifuged 
at 4°C, 10  min, 13,000 ×  g and then washed once in medium 
B. To isolate VDAC proteins, the pellet of isolated mitochondria 
was suspended in the solubilization buffer containing 3% Triton 
X-100, 10  mM Tris–HCl (pH 7.0), and 1  mM EGTA and was 
incubated for 30 min on ice. Then, 0.6 ml of the suspension was 
loaded onto a dry hydroxyapatite/celite column (33), and three 
fractions of 200 μl were collected. The presence of human VDAC 
isoforms were confirmed by liquid chromatography coupled 
to tandem mass spectrometry (LC–MS/MS) performed in the 
Laboratory of Mass Spectrometry, Institute of Biochemistry and 
Biophysics, Polish Academy of Sciences (Warsaw, Poland). The 
LC–MS/MS data, including the Exponentially Modified Protein 
Abundance Index (emPAI), were also used to indicate quantita-
tive relations between the isoforms and to detect proteins present 
in the obtained VDAC preparations.
conductance Measurements in Black 
lipid Membrane system
Artificial phospholipid membranes were formed from soybean 
asolectin (Avanti Polar Lipids, purified by acetone precipitation 
before use) suspended at concentration of 25 mg/ml in n-decane, 
across a circular hole (aperture diameter about 250 μm) in the 
thin wall of Delrin chamber (Warner Instruments) separating 
two compartments (cis–trans) filled with unbuffered 1M KCl 
(31, 34, 35). The pH of KCl solution was 6.9. The chamber was 
connected to the recording equipment through a matched pair 
of Ag–AgCl electrodes. About 0.1–0.5 μg of VDAC preparations 
were added to the cis compartment after membrane forma-
tion. Cis also refers to the compartment where the voltage was 
held. The voltage-dependence was determined due to current 
measurements probed with triangular voltage waves (10 mHz in 
frequency and 60 mV in amplitude). Signals were amplified by 
BLM-120 bilayer amplifier (Bio-LOGIC Science Instruments), 
and computer software was used for data collection. The average 
amount of analyzed insertion events for a given potential value 
and VDAC preparation was 45.
Other Methods
Protein concentration was measured by the method of Bradford 
and albumin bovine serum (BSA), essentially fatty acid free, 
was used as a standard. Taking into account the increased 
absorption of the dye by BSA, in the case of isolated VDAC 
preparations the correction factor obtained due to application 
of BSA and ovalbumin as standards was applied. Expression of 
Htt and mHtt was monitored by their labeling with GFP and 
ZEISS OBSERVER.Z1 fluorescence microscope.
resUlTs
Viability of Pc12 cells expressing htt or 
mhtt and Their status of Mitochondrial 
coupling
To study HD pathogenesis, including the role of mitochondria, 
only the first exon of wild type and mutant huntingtin (Htt and 
mHtt, respectively) encoding genes are often applied because 
N-terminus fragments of the mutant protein have been shown 
to recapitulate several aspects of the full length protein toxicity 
(36). However, the role of mitochondria dysfunction is randomly 
studied in intact cells although the available data highlight the 
importance of the cellular environment (30).
To monitor viability of PC12 cells expressing Htt and mHtt 
(PC12 HD-Q23 and PC12 HD-Q74, respectively) for the studied 
periods of time (4, 12, 24, and 48  h), the number of cells 
that adhere to the bottom of the applied plates was calculated 
[e.g., Rantzsch et  al. (37)], and the data were verified by the 
application of MTT assay based on metabolic activity of living 
cells [e.g., Kupcsik (38)]. Then, the studied parameter values 
were used to calculate the change index between cells with 
and without expression of Htt and mHtt (Figure 1). Thus, the 
index value higher or smaller than 1 denotes an increase or 
a decrease in viability of cells with a given protein expression 
(i.e., Htt and mHtt) when compared with proper control cells 
(i.e., without induced expression of Htt and mHtt) cultured 
for the same period of time. The obtained results indicated 
that a clear difference in viability of PC12 HD-Q23 and PC12 
HD-Q74 cells occurred when Htt and mHtt expression lasted 
for 48 h. Namely, the expression of Htt did not appear to affect 
FigUre 1 | Viability changes of Pc12 hD-Q23 and Pc12 hD-Q74 cells 
with expression of htt and mhtt, respectively, induced for a given 
period of time. Cells were cultured in 24-well plates, and the expression of 
Htt and mHtt was performed for a given period of time. The change index for 
(a) cell number adhering to the bottom of the plates and (B) the MTT cell 
proliferation colorimetric assay. The change index was calculated between 
cells expressing Htt or mHtt and control cells, i.e., cultured for the same time 
but without Htt or mHtt expression. The data are presented as mean 
values ± SD of three independent experiments. Statistical analysis was 
based on t-test: * – not statistically significant, ** – not quite statistically 
significant (p = 0.067), *** – statistically significant (p < 0.05).
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PC12 HD-Q23 cell viability, but viability of PC12 HD-Q74 
cells decreased.
To estimate the role of mitochondria functional state for 
the observed difference, cell respiration and the status of 
mitochondrial coupling in intact PC12 HD-Q23 and PC12 
HD-Q74 cells were determined. It is well known that the 
rate of cell respiration is controlled by the respiratory state of 
mitochondria, which fluctuates between the resting state (state 
4; low oxygen uptake, the higher inner membrane potential) 
and the phosphorylating state (state 3; high oxygen uptake, 
the lower inner membrane potential). Thus, basal (actual) 
cell respiration oscillates between these two states (27, 28). 
The status of mitochondrial coupling in intact cells can be 
estimated by calculation of mitochondrial coupling efficiency 
and mitochondrial coupling capacity. As mentioned in Section 
“Materials and Methods,” they correspond to the state 3 con-
tribution to basal respiration and FCCP uncoupling capacity 
(the state U to state 4 ratio), respectively (29, 31). State 3 can 
be calculated by subtracting state 4 from basal respiration, and 
state 4 can be enforced by inhibitors of adenine nucleotide 
translocase or ATP synthase able to cross the cell membrane 
(i.e., by elimination of state 3), whereas state U (uncoupled state 
that connotes a maximal rate of oxygen uptake) can be induced 
by FCCP, which collapses the inner membrane potential. A 
representative trace applied for the calculations is shown in 
Figure  2A, and the calculated original data are presented in 
Table S1 in Supplementary Material.
The basal respiration, state 3 contribution to basal respira-
tion, and FCCP uncoupling capacity were calculated for PC12 
HD-Q23 and PC12 HD-Q74 cells expressing Htt and mHtt for a 
given period of time (4, 12, 24, and 48 h), and then change index 
was determined for these parameters between the cells and their 
counterparts cultured for the same time but without expression 
of Htt and mHtt (control cells). Therefore, the change index value 
higher or smaller than 1 denotes an increase or a decrease in a 
value of the studied parameter for cells with expression of Htt or 
mHtt when compared with control cells, respectively.
The values of the change index for basal respiration were 
shown in Figure  2B. It was evident that the impact of Htt 
and mHtt expression on basal respiration including fluctua-
tion effect was initially very similar when compared to the 
proper control cells. However, for the expression longer than 
8  h, a clear difference occurred between PC12 HD-Q23 and 
PC12 HD-Q74 cells and concerned also the extent of the 
observed fluctuation. Namely, very weak, if any, changes of 
basal respiration were observed for PC12 HD-Q74 cells with 
mHtt expression lasted for 24 and 48  h when compared to 
control cells whereas for PC12 HD-Q23 cells with Htt expres-
sion lasted for 24 and 48 h, a strong increase and decrease of 
the basal respiration occurred when compared with control 
cells. To check whether the changes of basal respiration may 
result from changes of mitochondrial coupling efficiency, the 
contribution of state 3 to basal respiration was calculated and 
then compared between PC12 HD-Q23 and PC12 HD-Q74 cells 
with and without expression of Htt and mHtt, respectively, due 
to determination of the change index. As shown in Figure 2C, 
for the studied durations of Htt and mHtt expression, no 
important differences were observed for PC12 HD-Q23 and 
PC12 HD-Q74 cells when compared to the proper control 
cells, except for the expression lasted for 48 h when a slightly 
stronger decrease in the state 3 contribution to basal respiration 
was calculated for PC12 HD-Q23. Since actual mitochondrial 
coupling efficiency may result from the demand for ATP and/
or mitochondrial coupling capacity, FCCP uncoupling capacity 
was calculated and compared for the studied cells to determine 
the change index (Figure  2D). Interestingly, no differences 
were observed for PC12 HD-Q23 and PC12 HD-Q74 cells 
when compared to the proper control cells except for Htt and 
mHtt expression performed for 48  h. In this case, a distinct 
decrease of FCCP uncoupling capacity was calculated for PC12 
HD-Q23 cells whereas for PC12 HD-Q74 cells a slight increase 
FigUre 2 | changes of the mitochondrial coupling status in intact Pc12 hD-Q23 and Pc12 hD-Q74 cells with expression of htt and mhtt, 
respectively, induced for a given period of time. (a) A representative trace applied for further calculations. The rate of oxygen uptake by cells (2 × 106) was 
measured at 37°C in DMEM. Oligo, oligomycin. The calculated values of the change index for (B) basal respiration, (c) state 3 contribution to basal respiration, 
and (D) FCCP uncoupling capacity. The change index was calculated between cells expressing Htt or mHtt and control cells, i.e., cultured for the same time but 
without Htt or mHtt expression. State 4 was enforced by the addition of 2 μg/ml oligomycin, and state 3 was calculated by subtracting state 4 from basal 
respiration. The optimal concentration of FCCP yielding the highest respiratory rate (state U) was settled by the uncoupler addition in portions of 1 μM each. The 
FCCP uncoupling capacity denotes state U to state 4 ratio. The data are presented as mean values ± SD of three independent experiments. Statistical analysis 
was based on t-test: * – not statistically significant, ** – statistically significant (p < 0.05).
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of the parameter was obtained. Thus, the latter coincided with 
differences in mitochondrial coupling efficiency and the cell 
viability as determined by the proper change index values.
VDac activity in Pc12 cells expressing 
htt or mhtt and Differing in the status 
of Mitochondrial coupling
The differences in the status of mitochondrial coupling, observed 
for PC12 HD-Q23 and PC12 HD-Q74 cells with expression of 
Htt and mHtt lasted for 48 h, may result from differences in the 
permeability of the mitochondrial outer membrane. Therefore, 
VDAC was isolated from the cells cultured for 48 h under condi-
tions of the presence and absence of Htt and mHtt expression to 
estimate the channel properties after reconstitution in artificial 
phospholipid membranes (BLM system). The analysis of the 
emPAI provided with LC–MS/MS data concerning the isolated 
VDAC preparations indicated that the most abundant VDAC 
isoform in PC12 HD-Q23 and PC12 HD-Q74 cells was VDAC1. 
The isoform represented about 65–75% of all VDAC proteins, 
whereas the contribution of VDAC2 and VDAC3 was smaller 
and comparable. Importantly, the quantitative relationships were 
not changed by Htt and mHtt expression performed for 48  h 
(Figure 3).
It is well known that VDAC behavior in planar phospholipid 
membranes is voltage-dependent and symmetrical [e.g., Benz 
(39); Colombini et al. (40)], meaning that the channel closes at 
about the same rate and to about the same extent depending on 
the applied potential value but regardless its sign. Thus, at lower 
voltages the reconstituted VDAC displays the ability to adopt 
a fully open state that is anion selective with a conductance of 
about 4 nS in 1M KCl and transits into multiple closed states of 
significantly smaller conductance and anionic selectivity and 
consequently changed permeability when the voltage is increased.
As shown in Figure  4A, in the case of VDAC prepara-
tions isolated from PC12 HD-Q23 cells with or without Htt 
FigUre 3 | Quantitation of VDac isoforms in VDac preparations 
isolated from Pc12 hD-Q23 and Pc12 hD-Q74 cells. The quantitation 
was based on emPAI. The data are presented as mean values ± SD of three 
independent experiments. Q23 non-induced and Q74 non-induced denote 
PC12 HD-Q23 and PC12 HD-Q74 cells cultured for 48 h without expression 
of Htt and mHtt, respectively, whereas Q23 induced and Q74 induced 
denote the cells with the proper expression lasted for 48 h.
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expression and PC12 HD-Q74 cells without mHtt expression, 
the obtained distributions of conductance recorded at the mem-
brane potential of +10 mV indicated the dominance of the fully 
open state with the conductance of about 4 nS in 1M KCl that is 
consistent with published data. However, in the case of VDAC 
preparations isolated from PC12 HD-Q74 cells with mHtt 
expression, the conductance of the open state was decreased 
that suggested a higher frequency of the channel transition into 
closed states that might denote the changed voltage-dependence 
[e.g., Karachitos et al. (34)]. When the voltage-dependence was 
compared between VDAC preparations isolated from proper 
control cells and their counterparts with the expression of Htt or 
mHtt (Figure 4B), no effect was observed for Htt expression, but 
expression of mHtt affected the parameter distinctly. The effect 
consisted in the voltage-dependence decrease. Thus, after 48 h 
of mHtt expression in PC12 HD-Q74 cells, the isolated VDAC 
preparations with a dominant quantitative content of VDAC1 
displayed clear changes of basic VDAC channel characteristic 
not observed in the case of Htt expression.
DiscUssiOn
Here, we applied the known inducible model of HD comprising 
cycling PC12 HD-Q23 and PC12 HD-Q74 cells (25) to study the 
relationship between the cell viability, status of mitochondrial cou-
pling determined in intact cells, and VDAC properties estimated 
after reconstitution in artificial membranes. Significant difference 
in the cell viability occurs when Htt and mHtt expression lasted 
for 48 h (Figure 1). Namely, the viability does not appear to be 
affected in the case of PC12 HD-Q23 cells but decreases in the 
case of PC12 HD-Q74 cells. Thus, the duration of mHtt expres-
sion allows for observation of its cytotoxic effect.
It has been shown previously for the cell lines that no obvious 
compromise of the mitochondrial respiratory chain complexes 
occurs even after 72 h of mHtt expression as determined by their 
activity measurements in the cell extracts (25). However, it has 
also been shown that some mitochondria deficits in HD patho-
mechanism may only be detected in intact cells [e.g., Gouarné 
et al. (30)]. Our data confirm the assumption as distinct differ-
ences in cell respiration and the status of mitochondrial coupling 
are observed for PC12 HD-Q23 and PC12 HD-Q74 cells when 
compared to the proper control cells (Figure  2). Interestingly, 
the differences in basal respiration prelude differences in mito-
chondrial coupling efficiency (i.e., the state 3 contribution to 
basal respiration) and mitochondrial coupling capacity (i.e., the 
FCCP uncoupling capacity). The latter two are observed for Htt 
and mHtt expression lasted for 48  h whereas the difference in 
basal respiration occurs already after 24 h of the expression. Thus, 
manifestation of mHtt cytotoxic effect at the level of cell viability 
follows in time changes of basal respiration but coincides with 
changes of the mitochondrial coupling status.
Importantly, the changes of basal respiration determined for 
PC12 HD-Q23 and PC12 HD-Q74 cells in comparison with proper 
control cells fluctuate differentially. The fluctuations appear to be 
supported by the presence of Htt and eliminated by the presence 
of mHtt. Therefore, it may be suggested that the presence of mHtt 
may interfere with naturally occurring fluctuations of oxidative 
metabolism of cycling cells [e.g., Maldonado and Lemasters (14)], 
which seem to be supported by Htt. It is well known that proper 
progression of cell cycle requires significant energetic commit-
ments and therefore a timely boost of mitochondrial respiration. 
Accordingly, it has been shown that the respiratory chain complex 
I activation and resulting increase of mitochondrial respiration 
are vital for synchronization between mitochondrial activity and 
cell-cycle progression (41). Thus, as summarized herein, transient 
upregulation of mitochondrial respiration is important for suc-
cessful cell-cycle progression. Correspondingly, according to our 
preliminary data, when compared with proper control cells the 
number of PC12 HD-Q74 dividing cells decreases after induction 
of mHtt expression (not shown). Furthermore, it is proposed that 
Htt is necessary for mitochondrial structure and function from 
the earliest stages of embryogenesis (21).
The increased basal respiration observed transiently for PC12 
HD-Q23 cells and only initially for PC12 HD-Q74 cells when 
compared with proper control cells may imply differences in the 
rate of ATP synthesis and consequently transient differences in 
ATP content in these cells. The same may apply to the decreased 
level of basal respiration observed after 48 h of the proper protein 
synthesis for PC12 HD-Q23 cells but not for PC12 HD-Q74 cells. 
It might denote that differences in oxidative metabolism between 
cycling cells expressing Htt and mHtt may oscillate. Accordingly, 
as summarized by Brustovetsky (42), the available data support 
two different views on the interaction of mHtt with oxidative 
metabolism. One group of investigators reports detrimental 
effects of mHtt on ATP content, whereas another group does not 
find evidence for such an effect.
The metabolite exchange between mitochondria and cyto-
plasm is supported by VDAC, which is thus thought to act as 
a global regulator of the mitochondrial outer membrane perme-
ability and hence of mitochondrial functions [e.g., Homblé et al. 
(43)]. The protein can be characterized electrophysiologically 
FigUre 4 | The effect of htt and mhtt expression on reconstituted VDac preparations isolated from Pc12 hD-Q23 and Pc12 hD-Q74 cells, 
respectively, after the expression lasted for 48 h. (a) Histograms of conductances calculated at a membrane potential of +10 mV. The data reflect the following 
number of insertion events: Q23 non-induced, 41; Q23 induced, 52; Q74 non-induced, 41, and Q74 induced, 49 (B) The voltage-dependence assessed due to 
current measurements by triangular voltage waves. Gmax denotes average conductance values calculated in the presence of the lowest applied potential. The 
average amount of the analyzed insertions for a given potential value and VDAC preparation was 45 for 2–3 different preparations of VDAC proteins. Q23 
non-induced and Q74 non-induced denote PC12 HD-Q23 and PC12 HD-Q74 cells cultured for 48 h without expression of Htt and mHtt, respectively, whereas Q23 
induced and Q74 induced denote the cells with the proper expression lasted for 48 h.
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by determination of the reconstituted channel conductance and 
voltage-dependence. The calculated distributions of conduct-
ances recorded at a membrane potential of +10 mV for VDAC 
preparations isolated from PC12 HD-Q23 and PC12 HD-Q74 
cells (Figure  4) indicate that mHtt expression lasted for 48  h 
distinctly decreases the conductance of the open state, while 
expression of Htt does not affect the feature. Thus, the expression 
of mHtt may promote VDAC closing, a situation known to be 
accompanied by changes of VDAC selectivity toward cations (39, 
40). This, in turn, may influence metabolite exchange between 
mitochondria and cytoplasm leading to the observed changes of 
basal respiration and the mitochondrial coupling status.
Importantly, the effect of mHtt on VDAC conductance does 
not co-occur with the increased voltage-dependence. Conversely, 
a decrease of the voltage-dependence is observed for the VDAC 
preparations. Thus, it may be suggested that the decreased conduct-
ance of the open state and decreased voltage-dependence reflect 
VDAC functional changes occurring in cells with expression of 
mHtt. Correspondingly, we have observed that oxidative stress 
imposed by depletion of CuZnSOD in Saccharomyces cerevisiae 
cells (Δsod1cells) changes the properties of VDAC (34) in the 
same direction as that observed for PC12 HD-Q74 cells expressing 
mHtt. Therefore, it can be speculated that oxidative stress known 
to be caused by mHtt expression [e.g., Borza (44)] may contribute 
to the observed changes of VDAC properties. Accordingly, it has 
been reported that 48 h after induction of mHtt and Htt expression 
in other PC12 strain lines applied as HD model, PC12 HD-Q103 
cells display elevated mitochondrial ROS content when compared 
with PC12 HD-Q25 or control cells (45). It is, however, still 
unclear whether the observed changes of the reconstituted VDAC 
properties may result or/and contribute to oxidative stress.
It has been shown recently that all mammalian VDAC 
isoforms are able to form channels of comparable character-
istic (31, 46, 47). Therefore, it may be speculated that dynamic 
movement of N-terminal helix defined as the vital element of 
the voltage-dependence and resulting conductance control [e.g., 
De Pinto et  al. (48)] is impaired in all VDAC isoforms due to 
the protein modification or interaction with mHtt. However, 
taking into account the quantitative dominance of VDAC1 in the 
isolated VDAC preparations (Figure 3), it can be assumed that 
functional changes of the isoform contribute importantly to the 
observed effect. Correspondingly, it has been proposed that the 
mitochondrial outer membrane potential can range between 
−60 and +60 mV (49) although the issue has not been clarified 
till now. Nevertheless, the permeability of the membrane can be 
distinctly changed even in the presence of the small change of the 
fundamental VDAC feature.
The changes of VDAC properties imposed by the expression of 
mHtt may be also reflected by changes of a repertoire of interact-
ing proteins. Accordingly, α-tubulin is not detected in VDAC 
preparations isolated from PC12 HD-Q74 cells with expression 
of mHtt lasted for 48  h (Table S2 in Supplementary Material). 
This might denote elimination of its interaction with VDAC 
that results affects first basal respiration and then the status of 
mitochondrial coupling and cell viability. Accordingly, free 
tubulin-dependent differential modulation of mammalian VDAC 
isoforms is regarded to represent a new mechanism contributing 
to mitochondrial metabolism and consequently to cell viability 
(50–53). The modulation is described as a cyclic one and consist-
ing in VDAC reversible blockade. Free tubulin is a heterodimer 
of α- and β-tubulin, and in cells the dimer is under dynamic 
equilibrium with microtubules (tubular polymers of tubulin), 
which is determined by different factors including cell divisions 
(14, 50). As it is proposed that mHtt enhances oxidative stress 
and increases protein susceptibility to oxidative modifications 
(44, 54), and VDAC1 is known to be highly sensitive to oxidative 
stress [e.g., O’Brien et al. (55); Mello et al. (56); Karachitos et al. 
(34)], it can be hypothesized that resulting VDAC1 modifications 
may result in changes of the protein interaction with free tubulin. 
On the other hand, mHtt has been reported to be associated with 
microtubules (57). Moreover, free tubulin has been identified 
as an interacting partner of mHtt and Htt, but the interaction 
is stronger with mHtt (58). This, in turn, may counteract free 
tubulin interaction with VDAC1.
Summing up, the presented data indicate that the first meas-
urable mitochondrial symptom of mHtt expression in inducible 
PC12 cell model of HD is a change of basal respiration and 
subsequent change of the cell viability. The latter co-occurs with 
changes of the status of mitochondrial coupling in intact cells and 
changes of VDAC, being probably mainly VDAC1, properties. 
Therefore, the data appear to be important for better understand-
ing of cellular processes resulting in cell death. Thus, they may 
contribute to development of both cytoprotective and cytotoxic 
strategies of a clinical applicability.
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